Author

Weiyue Lu

Fudan University - Cited by 12,685

Biography

Dr. Weiyue  Lu works in Department of Pharmaceutics, School of Pharmacy, Fudan University & Key Laboratory of Smart Drug Delivery (Fudan University), Ministry of Education, Shanghai, PR China, is a well-known researcher in field of Bioequivalence & Bioavailability. One of his renowned work is Active Targeting Liposomes: Promising Approach for Tumor-Targeted Therapy
Title
Cited by
Year
Interrogation of folic acid-functionalized nanomedicines: the regulatory roles of plasma proteins reexamined
H Wang, T Ding, J Guan, X Liu, J Wang, P Jin, S Hou, W Lu, J Qian, ...ACS nano 14 (11), 14779-14789, 2020202
55
2020
Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma
H Guo, R Wang, D Wang, S Wang, J Zhou, Z Chai, S Yao, J Li, L Lu, Y Liu, ...Journal of Controlled Release 320, 63-72, 2020202
34
2020
Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy
S Wang, R Wang, N Meng, H Guo, S Wu, X Wang, J Li, H Wang, K Jiang, ...Journal of Controlled Release 8, 78-86, 2020202
32
2020
Natural IgM dominates in vivo performance of liposomes
T Ding, J Guan, M Wang, Q Long, X Liu, J Qian, X Wei, W Lu, C ZhanJournal of Controlled Release 319, 371-381, 2020202
26
2020
All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide
D Ran, J Zhou, Z Chai, J Li, C Xie, J Mao, L Lu, Y Zhang, S Wu, C Zhan, ...Theranostics 10 (9), 4073, 2020202
23
2020
Enhanced mucosal penetration and efficient inhibition efficacy against cervical cancer of PEGylated docetaxel nanocrystals by TAT modification
F Lv, J Wang, H Chen, L Sui, L Feng, Z Liu, Y Liu, G Wei, W LuJournal of Controlled Release 336, 572-582, 2021202
22
2021
Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomes
X Wang, N Meng, S Wang, Y Zhang, L Lu, R Wang, H Ruan, K Jiang, ...Journal of Controlled Release 316, 381-392, 202
19
2019
Deciphering protein corona by scFv-based affinity chromatography
Y Chu, W Tang, Z Zhang, C Li, J Qian, X Wei, T Ying, W Lu, C ZhanNano Letters 21 (5), 2124-2131, 2021202
19
2021
Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines
Z Zhang, Y Chu, C Li, W Tang, J Qian, X Wei, W Lu, T Ying, C ZhanJournal of Controlled Release 330, 493-501, 2021202
16
2021
N-trimethyl chitosan coated nano-complexes enhance the oral bioavailability and chemotherapeutic effects of gemcitabine
G Chen, D Svirskis, W Lu, M Ying, H Li, M Liu, J WenCarbohydrate Polymers 273, 118592, 2021202
14
2021
Baicalein enhances the antitumor efficacy of docetaxel on nonsmall cell lung cancer in a β‐catenin‐dependent manner
L Lu, M Zhang, X Wang, Y Zhang, Z Chai, M Ying, J Guan, W Gong, ...Phytotherapy Research 34 (1), 104-117, 2020202
14
2020
Stapled RAP12 peptide ligand of LRP1 for micelles-based multifunctional glioma-targeted drug delivery
H Ruan, S Yao, S Wang, R Wang, C Xie, H Guo, W LuChemical Engineering Journal 403, 126296, 2021202
14
2021
Hydrogel loading functionalized PAMAM/shRNA complex for postsurgical glioblastoma treatment
J Song, H Zhang, D Wang, J Wang, J Zhou, Z Zhang, J Wang, Y Hu, Q Xu, ...Journal of Controlled Release 338, 583-592, 2021202
13
2021
The influx/efflux mechanisms of d-peptide ligand of nAChRs across the blood–brain barrier and its therapeutic value in treating glioma
B Han, W Xie, Y Zhang, S Zhou, J Yang, R Wang, Y Sun, X Wang, J Xu, ...Journal of Controlled Release 327, 384-396, 2020202
13
2020
All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals
S Wu, L Lu, J Zhou, D Ran, S Wang, Q Xu, W Xu, J Wang, Y Liu, C Xie, ...Journal of Controlled Release 345, 685-695, 2022202
12
2022
ɑvβ3-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy
J Li, Z Chai, J Lu, C Xie, D Ran, S Wang, J Zhou, W LuJournal of Controlled Release 322, 542-554, 2020202
11
2020
Core-shell lipoplexes inducing active macropinocytosis promote intranasal delivery of c-Myc siRNA for treatment of glioblastoma
Y Hu, K Jiang, D Wang, S Yao, L Lu, H Wang, J Song, J Zhou, X Fan, ...Acta Biomaterialia 138, 478-490, 2022202
10
2022
Sequential release of paclitaxel and imatinib from core–shell microparticles prepared by coaxial electrospray for vaginal therapy of cervical cancer
Z Liu, H Chen, F Lv, J Wang, S Zhao, Y Li, X Xue, Y Liu, G Wei, W LuInternational Journal of Molecular Sciences 22 (16), 8760, 2021202
9
2021
Unraveling GLUT‐mediated transcytosis pathway of glycosylated nanodisks
H Wang, Z Zhang, J Guan, W Lu, C ZhanAsian Journal of Pharmaceutical Sciences 16 (1), 120-128, 2021202
9
2021
Preformulation studies and enabling formulation selection for an insoluble compound at preclinical stage—from in vitro, in silico to in vivo
L Zhang, H Luan, W Lu, H WangJournal of Pharmaceutical Sciences 109 (2), 950-95, 2020202
8
2020

Referred From: https://scholar.google.com/citations?hl=en&user=SUJ1BioAAAAJ

Cited by
Citations 12685
h-index 66
i10-index 191
Recommended Journals
Open Access Journals